Design Therapeutics Inc (DSGN) — Financial Flexibility Index
Design Therapeutics Inc (DSGN) has a Financial Flexibility Index of -0.93x as of September 2025. Free cash flow of $-11.16 Million (operating CF $-11.16 Million minus capex $0.00) represents -1% of total liabilities ($12.05 Million). Check Design Therapeutics Inc (DSGN) tangible equity ratio to evaluate the tangible quality of the company's equity base.
Financial Flexibility Index
Free Cash Flow
Total Liabilities
Capital Expenditures
Design Therapeutics Inc Financial Flexibility Index (2019–2024)
Historical Financial Flexibility Index trend for Design Therapeutics Inc across 6 annual periods. For the full cash flow conversion analysis, see Design Therapeutics Inc (DSGN) cash conversion ratio.
Annual Financial Flexibility Index for Design Therapeutics Inc (2019–2024)
Year-by-year free cash flow to debt coverage for Design Therapeutics Inc. Explore debt repayment capacity of Design Therapeutics Inc to assess how comfortably operating cash covers total debt obligations.
| Year | Flexibility Index | Free Cash Flow (USD) | Operating CF | Total Liabilities | YoY Change |
|---|---|---|---|---|---|
| 2024 | -4.28x | $-42.77 Million | $-43.10 Million | $10.00 Million | ▲ +12.3% |
| 2023 | -4.88x | $-58.30 Million | $-58.56 Million | $11.96 Million | ▼ -33.8% |
| 2022 | -3.64x | $-50.40 Million | $-51.32 Million | $13.83 Million | ▼ -10.3% |
| 2021 | -3.30x | $-27.84 Million | $-29.38 Million | $8.43 Million | ▼ -1738.8% |
| 2020 | -0.18x | $-8.59 Million | $-8.67 Million | $47.83 Million | ▼ -964.2% |
| 2019 | -0.02x | $-63.00K | $-139.00K | $3.73 Million | — |